CommoditiesChemicals & PetrochemicalsSpecialty Chemicals

Omkar Speciality Chemicals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 18 filings·Updated 15 Oct 2026
Showing 10 of 18 filings.
15 Oct 20262 filings
Company UpdateChange in Directorate

Omkar Speciality Chemicals Limited has informed the Exchange about Resignation of Director/KMP/SMP

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:53View Source
Company UpdateChange in Directorate

Omkar Speciality Chemicals approves independent director appointment; resigns existing independent director

Appointment of Independent Director

  • Appointment: Shashi Kala Dhabriya appointed Additional Non-Executive Independent Director, effective Oct 15, 2026, for five years.
  • Subject to members' approval.
  • Profile: Shashi Kala Dhabriya, MA History; not related to directors; not debarred by SEBI.

Resignation of Independent Director

  • Resignation: Muskaan Pherwani ceased as Additional Non-Executive Independent Director, effective Oct 13, 2026.
  • Ceases membership in all committees and positions.
  • Reason: personal and professional commitments.
  • Not a director in any listed entity.
Filed 19:16View Source
28 Sept 20261 filing
Company UpdateGeneral

ROC grants 3-month AGM extension for Omkar Speciality Chemicals

AGM extension

  • FY ended 31/03/2026; AGM due 30/09/2026.
  • 3-month extension approved for AGM under Section 96(1) CA 2013.
  • ROC Mumbai II letter dated 28/09/2026 confirms extension.
Filed 18:25View Source
2 Sept 20261 filing
Company UpdateClarification - Financial Results

The Exchange has sought clarification from Omkar Speciality Chemicals Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 14:16View Source
15 Aug 20261 filing
Company UpdateNewspaper Publication

Submission of newspaper publication of unaudited financial results for quarter result ended 30 June 2026

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 18:00View Source
14 Aug 20261 filing
Board MeetingOutcome of Board Meeting

Omkar Speciality approves Q1 2026 unaudited results; notes going-concern due to NCLT resolution plan

Financial results

  • Unaudited quarterly results for quarter ended 30 June 2026 approved by Board.
  • Limited Review Report issued; going concern due to NCLT resolution plan.
  • Loss for quarter Rs 36.07 Lakhs; no revenue reported.
  • Going concern basis maintained; repayments to financial creditors completed.
  • Resolution Plan implemented per NCLT order dated 31 July 2025.

Notes on regulatory/compliance

  • Single business segment; segment reporting not applicable.
  • Figures for prior periods regrouped/reclassified where necessary.
Filed 20:11View Source
10 Aug 20262 filings
Board Meeting

Omkar Speciality Chemicals to hold board meeting on Aug 14, 2026 to consider unaudited Q2 2026 results

Meeting Details

  • Meeting date is 14 August 2026; time and venue not disclosed.

Key Agenda Items

  • Consider unaudited financial results for the quarter ended 30 June 2026.

Other Notes

  • Trading in the company's securities suspended w.e.f. 29 April 2026.
Filed 13:31View Source
Company UpdateNewspaper Publication

Newspaper Advertisement

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 10:42View Source
7 Aug 20262 filings
Company UpdateRevision of outcome

Revised outcome

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:06View Source
ResultFinancial Results

Omkar Speciality Chemicals confirms CIRP revival plan; negative net worth; new board appointed

Corporate actions & going concern

  • CIRP admitted on 5 December 2022; NCLT approved Resolution Plan on 31 July 2025.
  • New Board appointed from 1 January 2026.
  • Going concern: net worth remains negative; results prepared on going concern basis.

Financial performance & accounting notes

  • Q3 FY22: Revenue from operations 116.50 L, Total income 117.81 L, PBT -190.06 L, EPS -0.92.
  • 9M ended Sep-2022: Total income 595.08 L; Profit before tax -576.74 L.
  • Notes indicate unaudited results; limited review performed; Ind AS 34.

Revival status & disclosures

  • Results are unaudited/limited-reviewed with going concern and CIRP disclosures.
  • Resolution Plan approved by NCLT; new board appointed from Jan 2026; revival focus.
Filed 18:58View Source
Showing 10 of 18 filings